A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 492,600 shares of HRMY stock, worth $16.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
492,600
Previous 595,800 17.32%
Holding current value
$16.8 Million
Previous $18 Million 9.48%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$30.0 - $39.95 $3.1 Million - $4.12 Million
-103,200 Reduced 17.32%
492,600 $19.7 Million
Q2 2024

Aug 09, 2024

BUY
$28.81 - $33.01 $6.21 Million - $7.12 Million
215,700 Added 56.75%
595,800 $18 Million
Q1 2024

May 13, 2024

BUY
$29.93 - $35.06 $3.64 Million - $4.26 Million
121,600 Added 47.04%
380,100 $12.8 Million
Q4 2023

Feb 13, 2024

SELL
$19.2 - $33.78 $645,120 - $1.14 Million
-33,600 Reduced 11.5%
258,500 $8.35 Million
Q3 2023

Nov 14, 2023

SELL
$31.89 - $39.03 $3.77 Million - $4.62 Million
-118,300 Reduced 28.83%
292,100 $9.57 Million
Q2 2023

Aug 11, 2023

SELL
$30.5 - $37.4 $1.69 Million - $2.07 Million
-55,400 Reduced 11.89%
410,400 $14.4 Million
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $3.79 Million - $6.64 Million
123,100 Added 35.92%
465,800 $15.2 Million
Q4 2022

Feb 13, 2023

BUY
$45.4 - $60.91 $803,580 - $1.08 Million
17,700 Added 5.45%
342,700 $18.9 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.4 Million - $1.84 Million
33,200 Added 11.38%
325,000 $14.4 Million
Q2 2022

Aug 12, 2022

BUY
$33.54 - $52.15 $5.01 Million - $7.79 Million
149,300 Added 104.77%
291,800 $14.2 Million
Q1 2022

May 13, 2022

BUY
$33.14 - $51.13 $255,178 - $393,701
7,700 Added 5.71%
142,500 $6.93 Million
Q4 2021

Feb 11, 2022

BUY
$34.09 - $43.91 $3.25 Million - $4.19 Million
95,400 Added 242.13%
134,800 $5.75 Million
Q3 2021

Nov 12, 2021

BUY
$25.68 - $38.61 $708,768 - $1.07 Million
27,600 Added 233.9%
39,400 $1.51 Million
Q2 2021

Aug 13, 2021

BUY
$25.96 - $33.44 $306,328 - $394,592
11,800 New
11,800 $333,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.